The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...

Novo Nordisk, on the other hand, has taken a significant step by submitting a higher dose of its obesity treatment, Wegovy, to the European Medicines Agency. In the United States, the healthcare ...